Prediction of Inflammatory Response and Hypotensive Syndrome After Cardiac Surgery by Preoperative Copeptin Level
MicorSIRS
Prognostic Value of Copeptin Level Before Cardiac Surgery and Involvement in Systemic Inflammatory Response Syndrome After Cardiopulmonary Bypass
1 other identifier
observational
200
1 country
1
Brief Summary
The purpose of this study is to find a preoperative biomarker before cardiac surgery with cardiopulmonary bypass related to severe postoperative inflammatory response and circulatory complications. The investigators hypothesize that an increase of the preoperative stimulation of vasopressinergic system (in response to acute or chronic conditions) could lead to a microcirculatory dysfunction and favor the occurrence of vasodilatation during and after CPB and increase the symptoms of an inflammatory response after CPB. By defining a high risk population, a targeted strategy of monitoring and early or preventive treatment could improve postoperative prognosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
May 9, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedFirst Posted
Study publicly available on registry
September 20, 2017
CompletedSeptember 25, 2017
May 1, 2017
6 months
May 9, 2017
September 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Preoperative copeptin level
Plasmatic copeptine will be measured from routine blood sample on heparinazed tubes. The biological assay will be performed by Time-Resolved Amplified Cryptate Emission on automate Kryptor Compact plus (ThermoFisher, Clichy, France). A level above the 97° percentile of referent population will be considered pathological.
Preoperative 24 hours
Secondary Outcomes (13)
Postoperative microcirculatory impairment
Within 2h of admission in intensive care unit, before weaning of sedation and mechanical ventilation
Occurrence of SIRS using classical definition
First postoperative 24 hours
Postoperative hemodynamical impairment
First postoperative 24 hours
Perioperative copeptin kinetics
24 hours before the operation until admission intensive care unit
Perioperative copeptin kinetics
postoperative day
- +8 more secondary outcomes
Study Arms (1)
With inflammatory response
Patients with postoperative inflammatory response as defined by the occurrence of severe SIRS and/or postoperative vasodilation syndrome. Severe SIRS is defined by meeting at least 2 SIRS criteria during 6 consecutive hours or at least 3 SIRS criterias. Classical SIRS criteria include: temperature \>38,3 or \<36°C, heart rate \>90/min, respiratory rate \>20/min or PaCO2 \<32mmHg, GB\>12000 ou \<4000 c/mm3. Postoperative vasodilation syndrome is defined by the need of continuous infusion of norepinephrine (whatever the dose) to maintain the mean arterial pressure above 60 mmHg associated to a cardiac index above or egal to 2.2 L/min/m2. Patients without postoperative severe SIRS and without postoperative vasodilation syndrome
Interventions
Measure of plasmatic copeptin from preoperative samples retained in a biorepository. Physicians are blinded to the result.
Eligibility Criteria
Patients hospitalized and scheduled for cardiac surgery
You may qualify if:
- Elective surgery
- Scheduled time of at least 24 hours
- Cardiopulmonary bypass
You may not qualify if:
- Urgent surgery within 24 hours of hospital admission
- Chronic renal failure with preoperative glomerular filtration rate below 45 ml/min
- Ongoing sepsis (ie uncontrolled endocarditis)
- Immunosuppressive therapy (solid organ transplant recipient)
- Previously included in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Montpellierlead
- Thermo Fisher Scientific, Inccollaborator
Study Sites (1)
Department of critical care, Arnaud de Villeneuve Hospital
Montpellier, 34295, France
Related Publications (2)
MacCallum NS, Finney SJ, Gordon SE, Quinlan GJ, Evans TW. Modified criteria for the systemic inflammatory response syndrome improves their utility following cardiac surgery. Chest. 2014 Jun;145(6):1197-1203. doi: 10.1378/chest.13-1023.
PMID: 24576975RESULTColson PH, Bernard C, Struck J, Morgenthaler NG, Albat B, Guillon G. Post cardiac surgery vasoplegia is associated with high preoperative copeptin plasma concentration. Crit Care. 2011;15(5):R255. doi: 10.1186/cc10516. Epub 2011 Oct 25.
PMID: 22026977RESULT
Biospecimen
Plasma: preoperative, ICU admission at POD0 and POD1 samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philippe Gaudard, MD
Montpellier University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2017
First Posted
September 20, 2017
Study Start
January 1, 2017
Primary Completion
July 1, 2017
Study Completion
August 1, 2017
Last Updated
September 25, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share